The results of previous studies suggesting that PDE9A inhibition can improve neurodegenerative diseases (e.g., Nagy et al., 2015; Sanders and Rajagopal, 2020; Sharma et al., 2020) may need to be reconsidered with the knowledge of this new finding. This evidence concerns the gene PDE9A and neurodegenerative disease.